FDA Clears First Device Specifically Designed to Assess Function After Concussion

FDA Clears First Device Specifically Designed to Assess Function After Concussion

The US Food and Drug Administration (FDA) has given its first-ever clearance for marketing of devices designed to help clinicians assess cognitive function immediately after a suspected brain injury or concussion.

Called Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric, the tool was approved under a new FDA category titled “Computerized Cognitive Assessment Aid for Concussion.” The test battery is already used by more than 7,400 high schools, 1,000 colleges and universities, and 900 clinical centers as a way to test cognitive skills such as word memory, reaction time, and word recognition. ImPACT is designed for use on individuals aged 12 to 59, and operates on a desktop or laptop computer; ImPACT Pediatric is intended for children aged 5 to 11, and is run on an iPad.

Full story of ImPACT device at APTA

ByFlex Therapist

FlexTherapist CEUs provides professional online training to Physical Therapists and Physical Therapist Assistants. Our courses are approved by boards throughout the United States for CE renewal. We blog about news and research related to the field of physical therapy that will keep licensed professionals informed.